Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children

NCT00364793 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Efavirenz (EFV) + Didanosine (ddI) + Emtricitabine (FTC)

Sponsor

Bristol-Myers Squibb